Joseph C. Papa is a seasoned executive with over 35 years in the healthcare and pharmaceutical sectors. He recently took on the role of Chief Executive Officer at Emergent BioSolutions, Inc. This is a new chapter for him, but it...

Joseph C. Papa is a seasoned executive with over 35 years in the healthcare and pharmaceutical sectors. He recently took on the role of Chief Executive Officer at Emergent BioSolutions, Inc. This is a new chapter for him, but it follows a notable career in leading large companies. Before Emergent, he was at Bausch + Lomb, where he served as CEO until mid-2023. Previously, he was at Valeant Pharmaceuticals, which later became known as Bausch Health Companies. Notably, Joseph has a solid academic background, with a Bachelor's degree in Business Administration from the University of Michigan. He has repeatedly demonstrated his ability to drive growth and transform businesses, making substantial impacts at each company he led. Under his leadership, companies have navigated challenges and pursued ambitious goals. Joseph is also known for entering executive agreements that align his compensation with the company's long-term success, echoing a broader trend in corporate governance. In 2023, he had a total compensation of approximately $9.5 million, highlighting the significant financial responsibilities he undertakes. With a focus on performance metrics, Joseph continues to steer his companies toward sustainable growth and shareholder value.